| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 747452 | 3,19-(4-Acetamido)benzylidineandrographolide | 0.0339770934764508 | 0.55669634 |
| NSC 749292 | 3-methoxy-1-nitrosopyrido[3,2:4,5]pyrrolo[1,2-c][1,2,3]benzotriazine | 0.0339770934764508 | 0.46375523 |
| NSC 749379 | Null | 0.0339770934764508 | 0.51266951 |
| NSC 763646 | (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole | 0.0339770934764508 | 0.30548131 |
| NSC 79563 | 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine | 0.0339770934764508 | 0.17796918 |
| NSC 88054 | Null | 0.0339770934764508 | 0.393434 |
| NSC 99733 | Rheumygin | 0.0339770934764508 | 0.075398324 |
| NSC 128571 | Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) | 0.0339770934764516 | 0.35928999 |
| NSC 169774 | Bromocriptine methanesulfonate | 0.0339770934764516 | 0.52942359 |
| NSC 22348 | 1H-Naphth[2,3-d]imidazole-4,9-dione, 1-(p-bromophenyl)- 2-methyl- | 0.0339770934764516 | 0.54648808 |